|
Volumn 105, Issue 1, 2001, Pages 219-229
|
Cerebellar synaptic protein expression in schizophrenia
|
Author keywords
Cerebellum; Human brain; mRNA; Neuropathology; Psychosis; Synapse
|
Indexed keywords
BRAIN PROTEIN;
CHLORPROMAZINE;
CLOZAPINE;
COMPLEXIN I;
COMPLEXIN II;
HALOPERIDOL;
MESSENGER RNA;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
SYNAPTOPHYSIN;
UNCLASSIFIED DRUG;
ADULT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
AUTORADIOGRAPHY;
BRAIN NERVE CELL;
CEREBELLUM CORTEX;
CEREBELLUM DISEASE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HISTOCHEMISTRY;
HUMAN;
HUMAN TISSUE;
IN SITU HYBRIDIZATION;
MALE;
NERVE CONDUCTION;
NEUROPATHOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
SCHIZOPHRENIA;
SYNAPSE;
TISSUE LEVEL;
ACIDOSIS;
AGING;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
CEREBELLUM;
FEMALE;
GENE EXPRESSION REGULATION;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MIDDLE AGED;
NERVE TISSUE PROTEINS;
NEURONS;
RATS;
RATS, SPRAGUE-DAWLEY;
RNA, MESSENGER;
SCHIZOPHRENIA;
SYNAPSES;
SYNAPTOPHYSIN;
|
EID: 0035898259
PISSN: 03064522
EISSN: None
Source Type: Journal
DOI: 10.1016/S0306-4522(01)00141-5 Document Type: Article |
Times cited : (103)
|
References (64)
|